arrow
U

Ulrich Koller

university hospital of the paracelsus medical university salzburg
H指数:24
被引数:1,434

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

RiboScreenTM Technology Delivers Small-Molecule Ribodrugs to Convert Ribosomal Proteins into Molecular Valves for Tailored Protein Production Levels in Rare and Prevalent Disease

RiboScreenTM技术将小分子核糖体药物递送至细胞,将核糖体蛋白转化为分子阀门,以调节罕见病和常见病中定制化的蛋白质生产水平

2026-06-240
OA
Prime editing as a promising therapeutic strategy for junctional epidermolysis bullosa

连接性表皮松解症的潜在治疗策略:碱基编辑

2025-10-300
OAAI
HMCN1 variants aggravate epidermolysis bullosa simplex phenotype

HMCN1变体加重单纯性大疱性表皮松解症表型

2025-02-201
OA
Metformin shows anti-neoplastic properties by inhibition of oxidative phosphorylation and glycolysis in epidermolysis bullosa-associated aggressive cutaneous squamous cell carcinoma
2023-09-194
OA
MicroRNA-200b-mediated reversion of a spectrum of epithelial-to-mesenchymal transition states in recessive dystrophic epidermolysis bullosa squamous cell carcinomas
2023-09-082
OA
Paired nicking-mediated COL17A1 reframing for junctional epidermolysis bullosa
2022-08-0115
OAAI
QR-313, an Antisense Oligonucleotide, Shows Therapeutic Efficacy for Treatment of Dominant and Recessive Dystrophic Epidermolysis Bullosa: A Preclinical Study
2021-04-0139
OAAI
Cancer-type organic anion transporting polypeptide 1B3 is a target for cancer suicide gene therapy using RNA trans-splicing technology

癌症型有机阴离子转运多肽1B3是使用RNA反式剪接技术进行癌症自杀基因治疗的靶标

2018-10-019
PRE